GO
| HSI1 | 26,241.83 | -244.07 | 209.64B |
| HSCEI1 | 9,267.56 | -88.41 | 76.99B |
| Back Zoom + Zoom - Block Traded | |
|
Lilly, Novo Reach Deal w/ White House to Axe Obesity Drug Prices
2025-11-07 01:23:00 US President Donald Trump announced on Thursday that an agreement has been reached with Eli Lilly And Co (LLY.US) and Novo Nordisk A/S (NVO.US) to sharply cut the prices of their blockbuster weight-loss drugs, a move aimed at expanding medication access for patients enrolled in the Medicare program. The agreement will lower the prices of GLP-1 drugs for Medicare and Medicaid beneficiaries in 2026, and discounts will be offered directly to consumers through a website named TrumpRx.gov. This website will be launched by the US government in January 2026. ~ AAStocks Financial News Web Site: www.aastocks.com | |